Ravindranath, M H <br/><br/>
Ganglioside GM3:GD3 ratio as an index for the management of melanoma.  [electronic resource] 

 -  Cancer  Jun 1991 
 - 3029-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19910615)67:12<3029::aid-cncr2820671217>3.0.co;2-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--analysis<br/>Chromatography<br/>Chromatography, High Pressure Liquid<br/>Chromatography, Thin Layer<br/>Female<br/>G(M3) Ganglioside--analysis<br/>Gangliosides--analysis<br/>Humans<br/>Lymphatic Metastasis<br/>Male<br/>Melanoma--chemistry<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Survival Rate